Objective: To evaluate the spectrum of intracranial complications of rhinoorbitocerebral mucormycosis utilizing MRI and to identify key risk factors and their impact on patient outcomes. Methods: This retrospective study included 21 patients diagnosed with rhinoorbitocerebral mucormycosis who underwent MRI to identify intracranial complications. The primary risk factors evaluated were Diabetes Mellitus type 2 (DM-2) and COVID-19 infection. Comparative analysis with existing literature was conducted to contextualize the findings. Results: Intracranial complications identified included abscess/cerebritis (58%), arterial infarct (29%), cavernous sinus thrombosis (17%), and internal carotid artery (ICA) thrombosis (11%). MRI findings were crucial in diagnosing these complications, showing T2 hyperintense lesions with ring enhancement for abscesses, restricted diffusion for infarcts, and signal changes in the cavernous sinus. Key risk factors identified were DM-2 (58%) and COVID 19 (35%), with 23% of patients having both conditions. The study revealed a high mortality rate of 64.7% among the patients. Conclusion: The study highlights the severe nature of rhinoorbitocerebral mucormycosis with significant intracranial complications. Early and aggressive intervention, particularly in patients with DM-2 and COVID-19, is crucial for improving outcomes. MRI plays a pivotal role in the early diagnosis and management of these complications.